|Videos|March 22, 2022
PharmExec CEO Roundtable: Post-COVID Improvements
In this segment, leaders suggest areas to continue building on lessons learned during COVID, including the pharma industry as a tech destination and impact on patient outcomes.
Advertisement
Please read the
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Enters $8.5 Billion Strategic Collaboration with Innovent Biologics and Acquires Orna Therapeutics
2
Articulating the Long-Term Value of AI-Powered Approaches
3
Hims & Hers Pulls Access to Compounded Semaglutide Pill Following Controversial Launch
4
Novo Nordisk Launches First Super Bowl Commercial for Wegovy Pill
5